ADAP - Adaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q1 2020 Results - Earnings Call Transcript
Adaptimmune Therapeutics plc (ADAP)
Q1 2020 Earnings Conference Call
May 14, 2020, 08:00 AM ET
Company Participants
Juli Miller - Director of IR
Adrian Rawcliffe - CEO
Helen Tayton-Martin - Chief Business Officer
Elliot Norry - Chief Medical Officer
Conference Call Participants
Marc Frahm - Cowen and Company
Tony Butler - Roth Capital
Mohit Bansal - Citigroup
Nick Abbott - Wells Fargo
Mara Goldstein - Mizuho
Presentation
Operator
Ladies and gentlemen, thank you for standing by. And welcome to the Adaptimmune Q1 2020 Earnings Conference Call. At this time, all participants' lines are in a